Session Information
Session Type: ACR Poster Session C
Session Time: 9:00AM-11:00AM
Background/Purpose: Children with chronic non-infectious uveitis are at high risk for sight-threatening complications and vision loss. No biomarker predicts uveitis development or treatment response. Aqueous humor has been studied but is not feasible to collect in children with JIA without eye disease. Tear proteomics is increasingly used for biomarker discovery in ocular and non-ocular diseases. Advantages of tear collection are easy accessibility, non-invasiveness and tolerance. We examined the tear profile of children with uveitis to identify potential markers for activity vs dormancy.
Methods: Tear samples were collected from children with chronic non-infectious uveitis (Table 1). A Schirmer strip was placed 6mm from the lateral canthus of the anesthetized eye for 2-5 minutes. Then, 50 ug of proteins were extracted for Tandem Mass Tag (TMT) labeling. The TMT pool was loaded onto an offline electrostatic repulsion interaction chromatography (ERLIC) fractionation HPLC system and 20 fractions were collected. LC-MS/MS analysis was done on all 20 fractions. Proteome Discoverer 2.1 (ThermoFisher Scientific, San Jose, CA) was used to search all the MS/MS spectra against a Uniprot human reference protein database (retrieved April 20, 2015; 90,411 target sequences) and TMT reporter quantitation was performed.
We compared children with 1) active vs inactive uveitis of all locations and 2) active vs. inactive anterior uveitis only (JIA-associated and idiopathic). Active uveitis was defined as anterior chamber cell grade of 0.5+ (1-5 cells/hpf) and greater. Inactive uveitis was grade 0.
Results: There were 19 children (29 eyes) examined. We quantified 1426 unique protein groups and found 34 and 39 statistically significant proteins, respectively for all uveitis and anterior uveitis only comparisons. Gene ontology showed pathways related to extracellular exosomes (adjusted p=10.6e-13 for all uveitis locations and p=1.23 e-14 for anterior uveitis only). In children with anterior uveitis only, there were pathways related to intracellular RNP complex (p=7.47 e-04), poly (A) RNA binding (p=0.002), and cadherin binding involved in cell-cell adhesion (p =0.012). These results suggest the homeostatic balance of translational and signaling machinery is disrupted during disease activity.
Conclusion: We identified potential biomarkers that may differentiate active ocular inflammation in children with uveitis. This may improve our understanding of the underlying mechanisms associated with ocular inflammation in children with JIA. Discovery of biomarkers in combination with clinical outcome measures may lead to better prediction of uveitis development and response to therapy.
Table 1. Demographics and Clinical Characteristics of Children with Chronic Non-infectious Uveitis, N (%) |
|||
|
ALL N = 19 children 29 eyes |
Active N = 12 children 10 eyes |
Inactive N = 7 children 19 eyes |
Female |
16 (84) |
10 (83) |
6 (86) |
Race |
|
|
|
Caucasian |
13 (68) |
6 (50) |
7 (100) |
African American |
6 (32) |
6 (50) |
0 |
Non-Hispanic |
17 (89) |
10 (83) |
7 (100) |
Age at uveitis diagnosis |
7.6 years |
8.5 years |
5.8 years |
Diagnosis |
|
|
|
JIA-associated uveitis (oligo or poly RF negative) |
9 (5) |
5 (42) |
4 (57) |
Idiopathic chronic anterior uveitis |
5 (26) |
4 (33) |
1 (14) |
Idiopathic uveitis, not anterior in location |
3 (16) |
3 (25) |
0 |
HLA-B27 associated |
2 (10) |
0 |
2 (28) |
Uveitis location |
|
|
|
Anterior |
15 (79) |
9 (75) |
6 (86) |
Anterior/ Intermediate |
1 (5) |
0 |
1 (14) |
Intermediate |
2 (10) |
2 (17) |
0 |
Posterior |
1 (5) |
1 (8) |
0 |
Bilateral |
16 (84) |
10 (83) |
6 (85) |
Medication use at time of collection |
|
|
|
Topical steroids (prednisolone acetate or difluprednate) |
12 (63) |
10 (83) |
2 (28) |
Timolol |
3 (16) |
3 (25) |
0 |
Methotrexate |
12 (63) |
10 (83) |
2 (28) |
Mycophenolate |
1 (5) |
|
1 (14) |
Lefunomide |
2 (10) |
1 (8) |
1 (14) |
Infliximab |
6 (32) |
3 (25) |
3 (43) |
Adalimumab |
3 (16) |
2 (17) |
1 (14) |
Tocilizumab |
2 (10) |
1 (8) |
1 (14) |
To cite this abstract in AMA style:
Angeles-Han S, Duong D, Yeh S, Patel P, Miraldi Utz V, Jenkins K, Lowe D, Prahalad S, Holland G. Quantitative Proteomics Comparison of Children with Inactive and Active Uveitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/quantitative-proteomics-comparison-of-children-with-inactive-and-active-uveitis/. Accessed .« Back to 2017 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantitative-proteomics-comparison-of-children-with-inactive-and-active-uveitis/